Skip to main content
Caplight Logo









eContinence AB

eContinence AB

Private
SwedenHealthcare & Life Scienceshttps://econtinence.app/

Last Round

Grant

May 1, 2022

Total Funding Raised

$20,000

Company Overview

eContinence AB is a med-tech company that develops and commercializes mobile health applications for the treatment of urinary incontinence and pelvic floor muscle training.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Telemedicine

Business Model

B2C

Customer Profile

Freemium

AI Layer

Non-AI

Keywords

urinary incontinencepelvic floor trainingdigital healthmHealthmedical devicepelvic floor exerciseskegel exercisesdigital therapeuticsDTxstress incontinenceprostate surgery recoveryself-management appCE-markedMDRtelemedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

eContinence AB Comparables

Compare eContinence AB with similar companies based on industry and business-model similarity.

eContinence AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Amara Therapeutics
82%
Agentis Health Group
79%
Fizimed
76%

eContinence AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 1, 2022
AcceleratorJul 1, 2021

eContinence AB Investors

Notable investors and investment history

eContinence AB investors
InvestorRounds
VinnovaGrant
Uminova InnovationAccelerator
Umeå Universitet Holding ABAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2025

    Monthly visitors grew 281% MoM, reaching 1.5K.

  • Jul 1, 2021

    Received funding from Uminova Innovation and Umeå Universitet Holding AB.

eContinence AB Filings

Explore SEC and related filing metadata, where available.

eContinence AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about eContinence AB's valuation, stock price, and market status.

Is eContinence AB a public or private company?

eContinence AB is a private company.

What is the current stock price of eContinence AB?

eContinence AB is a private company with no public stock price. Caplight tracks eContinence AB's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is eContinence AB worth (valuation)?

Valuation information for eContinence AB is not publicly available.

Can I buy eContinence AB stock?

eContinence AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was eContinence AB's last funding round?

eContinence AB's most recent funding round was Grant on May 1, 2022.

Who are the main investors in eContinence AB?

Key investors in eContinence AB include Vinnova, Uminova Innovation, Umeå Universitet Holding AB.

Will eContinence AB IPO soon?

No public IPO plans have been announced for eContinence AB.

How can I track eContinence AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor eContinence AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSweden
Employee Range2
Year Founded2021
Last FundingMay 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?